Diagnostic Contract Manufacturing Market by Device (In Vitro Diagnostic Devices and Diagnostic Imaging Devices), Service (Device Development & Manufacturing, Quality Management, and Packaging & Assembly), Application, Region - Global Forecast to 2028
The global diagnostic contract manufacturing market is projected to reach USD 44.9 Billion by 2028 from USD 26.0 Billion in 2023, at a CAGR of 11.5% during the forecast period. The growth of this market is majorly driven by the growth in the adoption of robotics and automation in manufacturing processes. However, the increasing adoption of refurbished diagnostic imaging systems challenges the growth of the diagnostic contract manufacturing market.
“The diagnostic imaging devices segment accounted for the highest growth rate in the diagnostic contract manufacturing market, by device, during the forecast period.”
Based on the type segment, the diagnostic contract manufacturing market is segmented into In vitro diagnostic devices, diagnostic imaging devices, and other devices. Diagnostic imaging devices include CT, X-ray, MRI, Ultrasound, and other imaging devices. Due to rapid economic growth, the adoption of these devices is expected to increase in developing countries in the coming years.
“Orthopedics application segment accounted for the highest CAGR during the forecast period among diagnostic imaging devices application.”
Based on application, the diagnostic imaging devices market is segmented into cardiology, neurology, orthopedics, oncology, and others. In 2022, cardiology dominated the market, and orthopedics observed the highest growth rate. Factors supporting the growth of orthopedics applications are the rising geriatric population and the growing prevalence of orthopedic diseases and disorders.
“The Asia Pacific segment accounted for the highest growth rate in the diagnostic contract manufacturing systems market, by region, during the forecast period.”
Based on the region, the global diagnostic contract manufacturing market is categorized into North America, Europe, Asia Pacific, and Rest of the World. Asia Pacific is expected to witness a high growth rate during the forecast period. Low labor costs and rapidly changing healthcare infrastructure hold massive potential for the Asia Pacific diagnostic contract manufacturing market.
Breakdown of supply-side primary interviews by company type, designation, and region:
• By Company Type: Tier 1- 55%, Tier 2- 40%, and Tier 3- 5%
• By Designation: C-level - 37%, Director-level - 48%, and Others-15%
• By Region: North America- 56%, Europe -17%, Asia- Pacific -20%, and Rest of the World -7%
Prominent companies include Jabil Inc. (US), Flex Ltd. (Singapore), Plexus Corp. (US), Sanmina Corporation (US), TE Connectivity Ltd. (Switzerland), Celestica Inc. (Canada), Integer Holdings Corporation (US), Nipro Corporation (Japan), Thermo Fisher Scientific (US), West Pharmaceutical Services Inc. (US), Benchmark Electronics Inc. (US), Kimball Electronics Inc. (US), KMS Systems (US), Savyon Diagnostics (Israel), Nova Biomedical (US), Cenogenics Corporation (US), Cone Bioproducts (US), Avioq, Inc. (US), Philips-Medisize Corporation (US), Invetech (Australia), Meridian Bioscience, Inc. (US), Nolato AB (Sweden), Fujirebio (Japan), Sekisui (US), Prestige Diagnostics (UK), and Biokit (Spain).
Research Coverage
This research report categorizes the diagnostic contract manufacturing market by device (In Vitro Diagnostic Devices, Diagnostic Imaging Devices, Other Devices), services (Device Development and Manufacturing Services, Quality Management Services, Packaging and Assembly Services, and Other Services), end-user (In Vitro Diagnostic Devices (Infectious Diseases, Oncology, Cardiology, Others), Diagnostic Imaging Devices (Cardiology, Oncology, Orthopedics, Neurology, Others), Other Devices (Gastroenterology, Gynecology, Others), and region (North America, Europe, Asia Pacific, and Rest of the World). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the diagnostic contract manufacturing market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product & service launches, mergers and acquisitions, and recent developments associated with the diagnostic contract manufacturing market. Competitive analysis of upcoming startups in the diagnostic contract manufacturing market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall diagnostic contract manufacturing market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
“The diagnostic imaging devices segment accounted for the highest growth rate in the diagnostic contract manufacturing market, by device, during the forecast period.”
Based on the type segment, the diagnostic contract manufacturing market is segmented into In vitro diagnostic devices, diagnostic imaging devices, and other devices. Diagnostic imaging devices include CT, X-ray, MRI, Ultrasound, and other imaging devices. Due to rapid economic growth, the adoption of these devices is expected to increase in developing countries in the coming years.
“Orthopedics application segment accounted for the highest CAGR during the forecast period among diagnostic imaging devices application.”
Based on application, the diagnostic imaging devices market is segmented into cardiology, neurology, orthopedics, oncology, and others. In 2022, cardiology dominated the market, and orthopedics observed the highest growth rate. Factors supporting the growth of orthopedics applications are the rising geriatric population and the growing prevalence of orthopedic diseases and disorders.
“The Asia Pacific segment accounted for the highest growth rate in the diagnostic contract manufacturing systems market, by region, during the forecast period.”
Based on the region, the global diagnostic contract manufacturing market is categorized into North America, Europe, Asia Pacific, and Rest of the World. Asia Pacific is expected to witness a high growth rate during the forecast period. Low labor costs and rapidly changing healthcare infrastructure hold massive potential for the Asia Pacific diagnostic contract manufacturing market.
Breakdown of supply-side primary interviews by company type, designation, and region:
• By Company Type: Tier 1- 55%, Tier 2- 40%, and Tier 3- 5%
• By Designation: C-level - 37%, Director-level - 48%, and Others-15%
• By Region: North America- 56%, Europe -17%, Asia- Pacific -20%, and Rest of the World -7%
Prominent companies include Jabil Inc. (US), Flex Ltd. (Singapore), Plexus Corp. (US), Sanmina Corporation (US), TE Connectivity Ltd. (Switzerland), Celestica Inc. (Canada), Integer Holdings Corporation (US), Nipro Corporation (Japan), Thermo Fisher Scientific (US), West Pharmaceutical Services Inc. (US), Benchmark Electronics Inc. (US), Kimball Electronics Inc. (US), KMS Systems (US), Savyon Diagnostics (Israel), Nova Biomedical (US), Cenogenics Corporation (US), Cone Bioproducts (US), Avioq, Inc. (US), Philips-Medisize Corporation (US), Invetech (Australia), Meridian Bioscience, Inc. (US), Nolato AB (Sweden), Fujirebio (Japan), Sekisui (US), Prestige Diagnostics (UK), and Biokit (Spain).
Research Coverage
This research report categorizes the diagnostic contract manufacturing market by device (In Vitro Diagnostic Devices, Diagnostic Imaging Devices, Other Devices), services (Device Development and Manufacturing Services, Quality Management Services, Packaging and Assembly Services, and Other Services), end-user (In Vitro Diagnostic Devices (Infectious Diseases, Oncology, Cardiology, Others), Diagnostic Imaging Devices (Cardiology, Oncology, Orthopedics, Neurology, Others), Other Devices (Gastroenterology, Gynecology, Others), and region (North America, Europe, Asia Pacific, and Rest of the World). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the diagnostic contract manufacturing market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product & service launches, mergers and acquisitions, and recent developments associated with the diagnostic contract manufacturing market. Competitive analysis of upcoming startups in the diagnostic contract manufacturing market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall diagnostic contract manufacturing market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers (early diagnosis and widening scope of clinical applications, adoption of robotics and automation in manufacturing processes, growing outsourcing activity by IVD manufacturers, and high cost of in-house IVD manufacturing), restraints (IP protection concerns and possibility of theft), opportunities (growth opportunities in emerging economies), and challenges (Increasing adoption of refurbished diagnostic imaging systems, lack of constant innovation to balance technological capabilities against costs, and shortage of skilled labor).
- Market Development: Comprehensive information about lucrative markets – the report analyses the diagnostic contract manufacturing market across varied regions.
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the diagnostic contract manufacturing market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Jabil Inc. (US), Flex Ltd. (Singapore), Plexus Corp. (US), Sanmina Corporation (US), TE Connectivity Ltd. (Switzerland), Celestica Inc. (Canada), among others in the diagnostic contract manufacturing market strategies.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
TABLE 1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
FIGURE 1 DIAGNOSTIC CONTRACT MANUFACTURING MARKET SEGMENTATION
1.3.1 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: RESEARCH DESIGN METHODOLOGY
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.3 KEY INDUSTRY INSIGHTS
2.1.3.1 Key data from primary sources
2.1.3.2 Breakdown of primary interviews
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach 1: Company revenue estimation approach
FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
2.2.1.2 Approach 2: Presentations of companies and primary interviews
2.2.1.3 Approach 3: COGS approach
FIGURE 6 DEMAND-SIDE ESTIMATION FOR DIAGNOSTIC CONTRACT MANUFACTURING MARKET
2.2.1.4 Approach 4: Parent market approach (in-house vs. outsourcing market)
2.2.1.5 Growth forecast
2.2.1.6 CAGR projections
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.2.2 TOP-DOWN APPROACH
FIGURE 8 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.4 STUDY ASSUMPTIONS
2.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: DIAGNOSTIC CONTRACT MANUFACTURING MARKET
3 EXECUTIVE SUMMARY
FIGURE 10 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 11 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 12 IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 13 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2023 VS. 2028 (USD MILLION)
4 PREMIUM INSIGHTS
4.1 DIAGNOSTIC CONTRACT MANUFACTURING MARKET OVERVIEW
FIGURE 14 HIGH COST OF IN-HOUSE MANUFACTURING TO DRIVE DEMAND FOR DIAGNOSTIC CONTRACT MANUFACTURING
4.2 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION (2023–2028)
FIGURE 15 ASIA PACIFIC MARKET TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
4.3 ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE AND COUNTRY (2022)
FIGURE 16 IVD DEVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC DIAGNOSTIC CONTRACT MANUFACTURING MARKET IN 2022
4.4 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 MARKET IN CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing demand for early diagnosis and widening scope of clinical applications
5.2.1.2 Adoption of robotics and automation in manufacturing processes
5.2.1.3 Growing outsourcing activity by IVD manufacturers
5.2.1.4 High cost of in-house IVD manufacturing
5.2.2 RESTRAINTS
5.2.2.1 IP protection concerns and possibility of IP theft
5.2.3 OPPORTUNITIES
5.2.3.1 Growth opportunities in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Increasing adoption of refurbished diagnostic imaging systems
5.2.4.2 Lack of constant innovation to balance technological capabilities against costs
5.2.4.3 Shortage of skilled labor
5.3 SUPPLY CHAIN ANALYSIS
FIGURE 19 DIAGNOSTIC CONTRACT MANUFACTURING: SUPPLY CHAIN
5.4 PORTER’S FIVE FORCES ANALYSIS
5.4.1 THREAT OF NEW ENTRANTS
5.4.2 THREAT OF SUBSTITUTES
5.4.3 BARGAINING POWER OF SUPPLIERS
5.4.4 BARGAINING POWER OF BUYERS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 ECOSYSTEM ANALYSIS
FIGURE 20 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: ECOSYSTEM ANALYSIS
5.5.1 ROLE IN ECOSYSTEM
FIGURE 21 KEY PLAYERS IN DIAGNOSTIC CONTRACT MANUFACTURING MARKET ECOSYSTEM
5.6 REGULATORY ANALYSIS
TABLE 3 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING DIAGNOSTIC CONTRACT MANUFACTURING
5.6.1 NORTH AMERICA
5.6.1.1 US
TABLE 4 US: CLASSIFICATION OF MEDICAL EQUIPMENT
5.6.1.2 Canada
5.6.2 EUROPE
5.6.3 ASIA PACIFIC
5.6.3.1 Japan
TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
TABLE 6 JAPAN: CLASSIFICATION OF IVD REAGENTS
5.6.3.2 China
TABLE 7 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.6.3.3 India
5.7 KEY CONFERENCES AND EVENTS IN 2022–2023
TABLE 8 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2022–2023
5.8 TECHNOLOGY ANALYSIS
6 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE
6.1 INTRODUCTION
TABLE 9 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
6.2 IN VITRO DIAGNOSTIC DEVICES
TABLE 10 IN VITRO DIAGNOSTIC DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 11 IN VITRO DIAGNOSTIC DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.1 IVD CONSUMABLES
6.2.1.1 Consumables segment to dominate IVD contract manufacturing market
TABLE 12 IVD CONSUMABLES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.2 IVD EQUIPMENT
6.2.2.1 Automation, advancements, and emphasis on efficient diagnostics to drive growth
TABLE 13 IVD EQUIPMENT: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3 DIAGNOSTIC IMAGING DEVICES
TABLE 14 DIAGNOSTIC IMAGING DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 15 DIAGNOSTIC IMAGING DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.1 CT
6.3.1.1 Rising adoption of CT scanners for detection of tumors to support growth
TABLE 16 CT: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.2 ULTRASOUND
6.3.2.1 Minimally invasive nature of ultrasound to boost demand
TABLE 17 ULTRASOUND: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.3 X-RAY
6.3.3.1 Low cost of X-ray imaging compared to other modalities to drive growth
TABLE 18 X-RAY: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.4 MRI
6.3.4.1 Innovation and advancement in MRI applications to drive demand
TABLE 19 MRI: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.5 OTHER DIAGNOSTIC IMAGING DEVICES
TABLE 20 OTHER DIAGNOSTIC IMAGING DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
6.4 OTHER DEVICES
TABLE 21 OTHER DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
7 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE
7.1 INTRODUCTION
TABLE 22 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
7.2 DEVICE DEVELOPMENT AND MANUFACTURING SERVICES
7.2.1 DEVICE MANUFACTURING SERVICES TO WITNESS HIGH GROWTH DURING FORECAST PERIOD
TABLE 23 DEVICE DEVELOPMENT AND MANUFACTURING SERVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
7.3 QUALITY MANAGEMENT SERVICES
7.3.1 STRINGENT REGULATIONS AND INCREASING PRODUCT SAFETY CONCERNS TO DRIVE DEMAND FOR QUALITY MANAGEMENT SERVICES
TABLE 24 QUALITY MANAGEMENT SERVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
7.4 PACKAGING AND ASSEMBLY SERVICES
7.4.1 INCREASING PRODUCT SAFETY CONCERNS FOR MEDICAL DEVICES TO SUPPORT GROWTH
TABLE 25 PACKAGING AND ASSEMBLY SERVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
7.5 OTHER SERVICES
TABLE 26 OTHER SERVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
8 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 IN VITRO DIAGNOSTIC DEVICE APPLICATIONS
TABLE 27 IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.2.1 INFECTIOUS DISEASES
8.2.1.1 Increasing incidence of infectious diseases to drive adoption of IVD devices
TABLE 28 INFECTIOUS DISEASES: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
8.2.2 DIABETES
8.2.2.1 Rising prevalence of diabetes to drive adoption of glucose monitoring devices
TABLE 29 DIABETES: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
8.2.3 ONCOLOGY
8.2.3.1 Rising initiatives for early detection of cancer to drive growth
TABLE 30 ONCOLOGY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
8.2.4 CARDIOLOGY
8.2.4.1 Increasing use of immunoassays in detection of CVD to drive growth
TABLE 31 CARDIOLOGY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
8.2.5 OTHER APPLICATIONS (IVD DEVICES)
TABLE 32 OTHER APPLICATIONS: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
8.3 DIAGNOSTIC IMAGING DEVICE APPLICATIONS
TABLE 33 DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.3.1 CARDIOLOGY
8.3.1.1 High prevalence of CVD to drive growth
TABLE 34 CARDIOLOGY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
8.3.2 ONCOLOGY
8.3.2.1 Wide adoption of nuclear imaging systems to distinguish between benign and malignant tumors to drive growth
TABLE 35 ONCOLOGY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
8.3.3 ORTHOPEDICS
8.3.3.1 Effective diagnosis and prognosis of musculoskeletal disorders by imaging devices to drive growth
TABLE 36 ORTHOPEDICS: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
8.3.4 NEUROLOGY
8.3.4.1 Innovations in 3D MRI technology to drive growth
TABLE 37 NEUROLOGY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
8.3.5 OTHER APPLICATIONS (DIAGNOSTIC IMAGING DEVICES)
TABLE 38 OTHER APPLICATIONS: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
8.4 OTHER DEVICE APPLICATIONS
TABLE 39 OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.4.1 GASTROENTEROLOGY
8.4.1.1 Surging demand for early diagnosis to propel growth
TABLE 40 ESTIMATED NEW GI CANCER CASES AND DEATHS IN US, 2021
TABLE 41 GASTROENTEROLOGY: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
8.4.2 GYNECOLOGY
8.4.2.1 Rising cases of cancer among women to drive growth
TABLE 42 GYNECOLOGY: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
8.4.3 OTHER APPLICATIONS (OTHER DEVICES)
TABLE 43 OTHER APPLICATIONS: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
9 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION
9.1 INTRODUCTION
TABLE 44 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2 ASIA PACIFIC
9.2.1 ASIA PACIFIC: IMPACT OF ECONOMIC RECESSION
FIGURE 22 ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET SNAPSHOT
TABLE 45 ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 46 ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 47 ASIA PACIFIC: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 48 ASIA PACIFIC: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 49 ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 50 ASIA PACIFIC: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 51 ASIA PACIFIC: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 52 ASIA PACIFIC: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.2.2 CHINA
9.2.2.1 Low labor costs and rapidly changing healthcare infrastructure to drive growth
TABLE 53 CHINA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 54 CHINA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 55 CHINA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 56 CHINA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 57 CHINA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 58 CHINA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 59 CHINA: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.2.3 JAPAN
9.2.3.1 Need for advanced medical diagnostic tools to fuel growth
TABLE 60 JAPAN: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 61 JAPAN: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 62 JAPAN: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 63 JAPAN: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 64 JAPAN: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 65 JAPAN: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 66 JAPAN: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.2.4 INDIA
9.2.4.1 Rising contract manufacturing capabilities to support growth
TABLE 67 INDIA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 68 INDIA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 69 INDIA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 70 INDIA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 71 INDIA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 72 INDIA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 73 INDIA: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.2.5 REST OF ASIA PACIFIC
TABLE 74 REST OF ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 75 REST OF ASIA PACIFIC: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 76 REST OF ASIA PACIFIC: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 77 REST OF ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 78 REST OF ASIA PACIFIC: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 79 REST OF ASIA PACIFIC: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 80 REST OF ASIA PACIFIC: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.3 NORTH AMERICA
9.3.1 NORTH AMERICA: IMPACT OF ECONOMIC RECESSION
FIGURE 23 NORTH AMERICA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET SNAPSHOT
TABLE 81 NORTH AMERICA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 82 NORTH AMERICA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 83 NORTH AMERICA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 84 NORTH AMERICA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 85 NORTH AMERICA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 86 NORTH AMERICA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 87 NORTH AMERICA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 88 NORTH AMERICA: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.3.2 US
9.3.2.1 Rising in-house manufacturing costs to drive shift toward contract manufacturing
TABLE 89 US: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 90 US: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 91 US: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 92 US: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 93 US: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 94 US: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 95 US: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.3.3 CANADA
9.3.3.1 Strong presence of key manufacturing companies to augment market
TABLE 96 CANADA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 97 CANADA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 98 CANADA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 99 CANADA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 100 CANADA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 101 CANADA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 102 CANADA: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.4 EUROPE
9.4.1 EUROPE: IMPACT OF ECONOMIC RECESSION
TABLE 103 EUROPE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 104 EUROPE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 105 EUROPE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 106 EUROPE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 107 EUROPE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 108 EUROPE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 109 EUROPE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 110 EUROPE: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.4.2 GERMANY
9.4.2.1 Germany to hold largest market share in Europe
TABLE 111 GERMANY: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 112 GERMANY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 113 GERMANY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 114 GERMANY: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 115 GERMANY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 116 GERMANY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 117 GERMANY: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.4.3 FRANCE
9.4.3.1 Strong focus on research and innovation of diagnostic devices to drive growth
TABLE 118 FRANCE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 119 FRANCE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 120 FRANCE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 121 FRANCE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 122 FRANCE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 123 FRANCE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 124 FRANCE: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.4.4 UK
9.4.4.1 Increasing accessibility of IVD devices to drive growth
TABLE 125 UK: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 126 UK: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 127 UK: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 128 UK: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 129 UK: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 130 UK: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 131 UK: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.4.5 ITALY
9.4.5.1 Lack of supporting infrastructure to restrain growth
TABLE 132 ITALY: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 133 ITALY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 134 ITALY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 135 ITALY: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 136 ITALY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 137 ITALY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 138 ITALY: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.4.6 SPAIN
9.4.6.1 Increasing demand for diagnostic equipment to boost demand for contract manufacturing
TABLE 139 SPAIN: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 140 SPAIN: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 141 SPAIN: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 142 SPAIN: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 143 SPAIN: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 144 SPAIN: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 145 SPAIN: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.4.7 REST OF EUROPE
TABLE 146 REST OF EUROPE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 147 REST OF EUROPE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 148 REST OF EUROPE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 149 REST OF EUROPE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 150 REST OF EUROPE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 151 REST OF EUROPE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 152 REST OF EUROPE: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.5 REST OF THE WORLD
9.5.1 LATIN AMERICA: IMPACT OF ECONOMIC RECESSION
9.5.2 MIDDLE EAST & AFRICA: IMPACT OF ECONOMIC RECESSION
TABLE 153 REST OF THE WORLD: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 154 REST OF THE WORLD: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 155 REST OF THE WORLD: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 156 REST OF THE WORLD: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 157 REST OF THE WORLD: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 158 REST OF THE WORLD: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 159 REST OF THE WORLD: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 STRATEGIES OF KEY PLAYERS/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY DIAGNOSTIC CONTRACT MANUFACTURERS
10.3 REVENUE ANALYSIS
FIGURE 24 REVENUE ANALYSIS OF KEY PLAYERS
10.4 MARKET SHARE ANALYSIS
FIGURE 25 IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET: DEGREE OF COMPETITION
FIGURE 26 DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET: DEGREE OF COMPETITION
10.5 COMPANY EVALUATION MATRIX
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 27 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: COMPANY EVALUATION MATRIX (2022)
10.6 FOOTPRINT ANALYSIS OF COMPANIES
TABLE 160 OVERALL FOOTPRINT OF COMPANIES
TABLE 161 DEVICE TYPE FOOTPRINT OF COMPANIES
TABLE 162 REGIONAL FOOTPRINT OF COMPANIES
10.7 COMPETITIVE BENCHMARKING
TABLE 163 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: LIST OF KEY START-UP/SME PLAYERS
10.8 COMPETITIVE SCENARIO
10.8.1 PRODUCT/SERVICE LAUNCHES AND APPROVALS
TABLE 164 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: PRODUCT/SERVICE LAUNCHES AND APPROVALS, 2020–2023
10.8.2 DEALS
TABLE 165 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: DEALS, 2020–2023
10.8.3 OTHER DEVELOPMENTS
TABLE 166 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: OTHER DEVELOPMENTS, 2020–2023
11 COMPANY PROFILES
(Business overview, Products/Services/Solutions offered, Recent Developments, MNM view)*
11.1 KEY PLAYERS
11.1.1 JABIL INC.
TABLE 167 JABIL INC.: COMPANY OVERVIEW
FIGURE 28 JABIL INC.: COMPANY SNAPSHOT (2022)
11.1.2 FLEX LTD.
TABLE 168 FLEX LTD.: COMPANY OVERVIEW
FIGURE 29 FLEX LTD.: COMPANY SNAPSHOT (2022)
11.1.3 PLEXUS CORP.
TABLE 169 PLEXUS CORP.: COMPANY OVERVIEW
FIGURE 30 PLEXUS CORP.: COMPANY SNAPSHOT (2022)
11.1.4 SANMINA CORPORATION
TABLE 170 SANMINA CORPORATION: COMPANY OVERVIEW
FIGURE 31 SANMINA CORPORATION: COMPANY SNAPSHOT (2022)
11.1.5 TE CONNECTIVITY LTD.
TABLE 171 TE CONNECTIVITY LTD.: COMPANY OVERVIEW
FIGURE 32 TE CONNECTIVITY LTD.: COMPANY SNAPSHOT (2022)
11.1.6 CELESTICA INC.
TABLE 172 CELESTICA INC.: COMPANY OVERVIEW
FIGURE 33 CELESTICA INC.: COMPANY SNAPSHOT (2022)
11.1.7 INTEGER HOLDINGS CORPORATION
TABLE 173 INTEGER HOLDINGS CORPORATION: COMPANY OVERVIEW
FIGURE 34 INTEGER HOLDINGS CORPORATION: COMPANY SNAPSHOT (2022)
11.1.8 NIPRO CORPORATION
TABLE 174 NIPRO CORPORATION: COMPANY OVERVIEW
FIGURE 35 NIPRO CORPORATION: COMPANY SNAPSHOT (2022)
11.1.9 THERMO FISHER SCIENTIFIC
TABLE 175 THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW
FIGURE 36 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2022)
11.1.10 WEST PHARMACEUTICAL SERVICES, INC.
TABLE 176 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY OVERVIEW
FIGURE 37 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT (2022)
11.1.11 BENCHMARK ELECTRONICS INC.
TABLE 177 BENCHMARK ELECTRONICS INC.: COMPANY OVERVIEW
FIGURE 38 BENCHMARK ELECTRONICS INC.: COMPANY SNAPSHOT (2022)
11.1.12 KIMBALL ELECTRONICS INC.
TABLE 178 KIMBALL ELECTRONICS INC.: COMPANY OVERVIEW
FIGURE 39 KIMBALL ELECTRONICS INC.: COMPANY SNAPSHOT (2022)
11.1.13 KMC SYSTEMS
TABLE 179 KMC SYSTEMS: COMPANY OVERVIEW
11.1.14 SAVYON DIAGNOSTICS
TABLE 180 SAVYON DIAGNOSTICS: COMPANY OVERVIEW
11.1.15 NOVA BIOMEDICAL
TABLE 181 NOVA BIOMEDICAL: COMPANY OVERVIEW
11.2 OTHER PLAYERS
11.2.1 CENOGENICS CORPORATION
11.2.2 CONE BIOPRODUCTS
11.2.3 AVIOQ, INC.
11.2.4 PHILLIPS-MEDISIZE CORPORATION
11.2.5 INVETECH
11.2.6 MERIDIAN BIOSCIENCE, INC.
11.2.7 NOLATO AB
11.2.8 FUJIREBIO
11.2.9 SEKISUI
11.2.10 PRESTIGE DIAGNOSTICS
11.2.11 BIOKIT
*Details on Business overview, Products/Services/Solutions offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
TABLE 1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
FIGURE 1 DIAGNOSTIC CONTRACT MANUFACTURING MARKET SEGMENTATION
1.3.1 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: RESEARCH DESIGN METHODOLOGY
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.3 KEY INDUSTRY INSIGHTS
2.1.3.1 Key data from primary sources
2.1.3.2 Breakdown of primary interviews
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach 1: Company revenue estimation approach
FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
2.2.1.2 Approach 2: Presentations of companies and primary interviews
2.2.1.3 Approach 3: COGS approach
FIGURE 6 DEMAND-SIDE ESTIMATION FOR DIAGNOSTIC CONTRACT MANUFACTURING MARKET
2.2.1.4 Approach 4: Parent market approach (in-house vs. outsourcing market)
2.2.1.5 Growth forecast
2.2.1.6 CAGR projections
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.2.2 TOP-DOWN APPROACH
FIGURE 8 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.4 STUDY ASSUMPTIONS
2.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: DIAGNOSTIC CONTRACT MANUFACTURING MARKET
3 EXECUTIVE SUMMARY
FIGURE 10 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 11 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 12 IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 13 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2023 VS. 2028 (USD MILLION)
4 PREMIUM INSIGHTS
4.1 DIAGNOSTIC CONTRACT MANUFACTURING MARKET OVERVIEW
FIGURE 14 HIGH COST OF IN-HOUSE MANUFACTURING TO DRIVE DEMAND FOR DIAGNOSTIC CONTRACT MANUFACTURING
4.2 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION (2023–2028)
FIGURE 15 ASIA PACIFIC MARKET TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
4.3 ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE AND COUNTRY (2022)
FIGURE 16 IVD DEVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC DIAGNOSTIC CONTRACT MANUFACTURING MARKET IN 2022
4.4 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 MARKET IN CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing demand for early diagnosis and widening scope of clinical applications
5.2.1.2 Adoption of robotics and automation in manufacturing processes
5.2.1.3 Growing outsourcing activity by IVD manufacturers
5.2.1.4 High cost of in-house IVD manufacturing
5.2.2 RESTRAINTS
5.2.2.1 IP protection concerns and possibility of IP theft
5.2.3 OPPORTUNITIES
5.2.3.1 Growth opportunities in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Increasing adoption of refurbished diagnostic imaging systems
5.2.4.2 Lack of constant innovation to balance technological capabilities against costs
5.2.4.3 Shortage of skilled labor
5.3 SUPPLY CHAIN ANALYSIS
FIGURE 19 DIAGNOSTIC CONTRACT MANUFACTURING: SUPPLY CHAIN
5.4 PORTER’S FIVE FORCES ANALYSIS
5.4.1 THREAT OF NEW ENTRANTS
5.4.2 THREAT OF SUBSTITUTES
5.4.3 BARGAINING POWER OF SUPPLIERS
5.4.4 BARGAINING POWER OF BUYERS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 ECOSYSTEM ANALYSIS
FIGURE 20 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: ECOSYSTEM ANALYSIS
5.5.1 ROLE IN ECOSYSTEM
FIGURE 21 KEY PLAYERS IN DIAGNOSTIC CONTRACT MANUFACTURING MARKET ECOSYSTEM
5.6 REGULATORY ANALYSIS
TABLE 3 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING DIAGNOSTIC CONTRACT MANUFACTURING
5.6.1 NORTH AMERICA
5.6.1.1 US
TABLE 4 US: CLASSIFICATION OF MEDICAL EQUIPMENT
5.6.1.2 Canada
5.6.2 EUROPE
5.6.3 ASIA PACIFIC
5.6.3.1 Japan
TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
TABLE 6 JAPAN: CLASSIFICATION OF IVD REAGENTS
5.6.3.2 China
TABLE 7 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.6.3.3 India
5.7 KEY CONFERENCES AND EVENTS IN 2022–2023
TABLE 8 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2022–2023
5.8 TECHNOLOGY ANALYSIS
6 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE
6.1 INTRODUCTION
TABLE 9 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
6.2 IN VITRO DIAGNOSTIC DEVICES
TABLE 10 IN VITRO DIAGNOSTIC DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 11 IN VITRO DIAGNOSTIC DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.1 IVD CONSUMABLES
6.2.1.1 Consumables segment to dominate IVD contract manufacturing market
TABLE 12 IVD CONSUMABLES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.2 IVD EQUIPMENT
6.2.2.1 Automation, advancements, and emphasis on efficient diagnostics to drive growth
TABLE 13 IVD EQUIPMENT: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3 DIAGNOSTIC IMAGING DEVICES
TABLE 14 DIAGNOSTIC IMAGING DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 15 DIAGNOSTIC IMAGING DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.1 CT
6.3.1.1 Rising adoption of CT scanners for detection of tumors to support growth
TABLE 16 CT: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.2 ULTRASOUND
6.3.2.1 Minimally invasive nature of ultrasound to boost demand
TABLE 17 ULTRASOUND: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.3 X-RAY
6.3.3.1 Low cost of X-ray imaging compared to other modalities to drive growth
TABLE 18 X-RAY: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.4 MRI
6.3.4.1 Innovation and advancement in MRI applications to drive demand
TABLE 19 MRI: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.5 OTHER DIAGNOSTIC IMAGING DEVICES
TABLE 20 OTHER DIAGNOSTIC IMAGING DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
6.4 OTHER DEVICES
TABLE 21 OTHER DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
7 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE
7.1 INTRODUCTION
TABLE 22 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
7.2 DEVICE DEVELOPMENT AND MANUFACTURING SERVICES
7.2.1 DEVICE MANUFACTURING SERVICES TO WITNESS HIGH GROWTH DURING FORECAST PERIOD
TABLE 23 DEVICE DEVELOPMENT AND MANUFACTURING SERVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
7.3 QUALITY MANAGEMENT SERVICES
7.3.1 STRINGENT REGULATIONS AND INCREASING PRODUCT SAFETY CONCERNS TO DRIVE DEMAND FOR QUALITY MANAGEMENT SERVICES
TABLE 24 QUALITY MANAGEMENT SERVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
7.4 PACKAGING AND ASSEMBLY SERVICES
7.4.1 INCREASING PRODUCT SAFETY CONCERNS FOR MEDICAL DEVICES TO SUPPORT GROWTH
TABLE 25 PACKAGING AND ASSEMBLY SERVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
7.5 OTHER SERVICES
TABLE 26 OTHER SERVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
8 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 IN VITRO DIAGNOSTIC DEVICE APPLICATIONS
TABLE 27 IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.2.1 INFECTIOUS DISEASES
8.2.1.1 Increasing incidence of infectious diseases to drive adoption of IVD devices
TABLE 28 INFECTIOUS DISEASES: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
8.2.2 DIABETES
8.2.2.1 Rising prevalence of diabetes to drive adoption of glucose monitoring devices
TABLE 29 DIABETES: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
8.2.3 ONCOLOGY
8.2.3.1 Rising initiatives for early detection of cancer to drive growth
TABLE 30 ONCOLOGY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
8.2.4 CARDIOLOGY
8.2.4.1 Increasing use of immunoassays in detection of CVD to drive growth
TABLE 31 CARDIOLOGY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
8.2.5 OTHER APPLICATIONS (IVD DEVICES)
TABLE 32 OTHER APPLICATIONS: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
8.3 DIAGNOSTIC IMAGING DEVICE APPLICATIONS
TABLE 33 DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.3.1 CARDIOLOGY
8.3.1.1 High prevalence of CVD to drive growth
TABLE 34 CARDIOLOGY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
8.3.2 ONCOLOGY
8.3.2.1 Wide adoption of nuclear imaging systems to distinguish between benign and malignant tumors to drive growth
TABLE 35 ONCOLOGY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
8.3.3 ORTHOPEDICS
8.3.3.1 Effective diagnosis and prognosis of musculoskeletal disorders by imaging devices to drive growth
TABLE 36 ORTHOPEDICS: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
8.3.4 NEUROLOGY
8.3.4.1 Innovations in 3D MRI technology to drive growth
TABLE 37 NEUROLOGY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
8.3.5 OTHER APPLICATIONS (DIAGNOSTIC IMAGING DEVICES)
TABLE 38 OTHER APPLICATIONS: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
8.4 OTHER DEVICE APPLICATIONS
TABLE 39 OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.4.1 GASTROENTEROLOGY
8.4.1.1 Surging demand for early diagnosis to propel growth
TABLE 40 ESTIMATED NEW GI CANCER CASES AND DEATHS IN US, 2021
TABLE 41 GASTROENTEROLOGY: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
8.4.2 GYNECOLOGY
8.4.2.1 Rising cases of cancer among women to drive growth
TABLE 42 GYNECOLOGY: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
8.4.3 OTHER APPLICATIONS (OTHER DEVICES)
TABLE 43 OTHER APPLICATIONS: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
9 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION
9.1 INTRODUCTION
TABLE 44 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2 ASIA PACIFIC
9.2.1 ASIA PACIFIC: IMPACT OF ECONOMIC RECESSION
FIGURE 22 ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET SNAPSHOT
TABLE 45 ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 46 ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 47 ASIA PACIFIC: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 48 ASIA PACIFIC: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 49 ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 50 ASIA PACIFIC: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 51 ASIA PACIFIC: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 52 ASIA PACIFIC: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.2.2 CHINA
9.2.2.1 Low labor costs and rapidly changing healthcare infrastructure to drive growth
TABLE 53 CHINA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 54 CHINA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 55 CHINA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 56 CHINA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 57 CHINA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 58 CHINA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 59 CHINA: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.2.3 JAPAN
9.2.3.1 Need for advanced medical diagnostic tools to fuel growth
TABLE 60 JAPAN: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 61 JAPAN: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 62 JAPAN: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 63 JAPAN: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 64 JAPAN: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 65 JAPAN: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 66 JAPAN: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.2.4 INDIA
9.2.4.1 Rising contract manufacturing capabilities to support growth
TABLE 67 INDIA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 68 INDIA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 69 INDIA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 70 INDIA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 71 INDIA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 72 INDIA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 73 INDIA: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.2.5 REST OF ASIA PACIFIC
TABLE 74 REST OF ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 75 REST OF ASIA PACIFIC: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 76 REST OF ASIA PACIFIC: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 77 REST OF ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 78 REST OF ASIA PACIFIC: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 79 REST OF ASIA PACIFIC: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 80 REST OF ASIA PACIFIC: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.3 NORTH AMERICA
9.3.1 NORTH AMERICA: IMPACT OF ECONOMIC RECESSION
FIGURE 23 NORTH AMERICA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET SNAPSHOT
TABLE 81 NORTH AMERICA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 82 NORTH AMERICA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 83 NORTH AMERICA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 84 NORTH AMERICA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 85 NORTH AMERICA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 86 NORTH AMERICA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 87 NORTH AMERICA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 88 NORTH AMERICA: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.3.2 US
9.3.2.1 Rising in-house manufacturing costs to drive shift toward contract manufacturing
TABLE 89 US: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 90 US: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 91 US: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 92 US: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 93 US: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 94 US: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 95 US: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.3.3 CANADA
9.3.3.1 Strong presence of key manufacturing companies to augment market
TABLE 96 CANADA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 97 CANADA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 98 CANADA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 99 CANADA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 100 CANADA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 101 CANADA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 102 CANADA: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.4 EUROPE
9.4.1 EUROPE: IMPACT OF ECONOMIC RECESSION
TABLE 103 EUROPE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 104 EUROPE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 105 EUROPE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 106 EUROPE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 107 EUROPE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 108 EUROPE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 109 EUROPE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 110 EUROPE: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.4.2 GERMANY
9.4.2.1 Germany to hold largest market share in Europe
TABLE 111 GERMANY: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 112 GERMANY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 113 GERMANY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 114 GERMANY: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 115 GERMANY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 116 GERMANY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 117 GERMANY: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.4.3 FRANCE
9.4.3.1 Strong focus on research and innovation of diagnostic devices to drive growth
TABLE 118 FRANCE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 119 FRANCE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 120 FRANCE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 121 FRANCE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 122 FRANCE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 123 FRANCE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 124 FRANCE: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.4.4 UK
9.4.4.1 Increasing accessibility of IVD devices to drive growth
TABLE 125 UK: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 126 UK: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 127 UK: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 128 UK: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 129 UK: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 130 UK: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 131 UK: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.4.5 ITALY
9.4.5.1 Lack of supporting infrastructure to restrain growth
TABLE 132 ITALY: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 133 ITALY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 134 ITALY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 135 ITALY: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 136 ITALY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 137 ITALY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 138 ITALY: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.4.6 SPAIN
9.4.6.1 Increasing demand for diagnostic equipment to boost demand for contract manufacturing
TABLE 139 SPAIN: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 140 SPAIN: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 141 SPAIN: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 142 SPAIN: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 143 SPAIN: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 144 SPAIN: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 145 SPAIN: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.4.7 REST OF EUROPE
TABLE 146 REST OF EUROPE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 147 REST OF EUROPE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 148 REST OF EUROPE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 149 REST OF EUROPE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 150 REST OF EUROPE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 151 REST OF EUROPE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 152 REST OF EUROPE: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.5 REST OF THE WORLD
9.5.1 LATIN AMERICA: IMPACT OF ECONOMIC RECESSION
9.5.2 MIDDLE EAST & AFRICA: IMPACT OF ECONOMIC RECESSION
TABLE 153 REST OF THE WORLD: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION)
TABLE 154 REST OF THE WORLD: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 155 REST OF THE WORLD: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 156 REST OF THE WORLD: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 157 REST OF THE WORLD: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 158 REST OF THE WORLD: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 159 REST OF THE WORLD: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 STRATEGIES OF KEY PLAYERS/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY DIAGNOSTIC CONTRACT MANUFACTURERS
10.3 REVENUE ANALYSIS
FIGURE 24 REVENUE ANALYSIS OF KEY PLAYERS
10.4 MARKET SHARE ANALYSIS
FIGURE 25 IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET: DEGREE OF COMPETITION
FIGURE 26 DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET: DEGREE OF COMPETITION
10.5 COMPANY EVALUATION MATRIX
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 27 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: COMPANY EVALUATION MATRIX (2022)
10.6 FOOTPRINT ANALYSIS OF COMPANIES
TABLE 160 OVERALL FOOTPRINT OF COMPANIES
TABLE 161 DEVICE TYPE FOOTPRINT OF COMPANIES
TABLE 162 REGIONAL FOOTPRINT OF COMPANIES
10.7 COMPETITIVE BENCHMARKING
TABLE 163 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: LIST OF KEY START-UP/SME PLAYERS
10.8 COMPETITIVE SCENARIO
10.8.1 PRODUCT/SERVICE LAUNCHES AND APPROVALS
TABLE 164 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: PRODUCT/SERVICE LAUNCHES AND APPROVALS, 2020–2023
10.8.2 DEALS
TABLE 165 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: DEALS, 2020–2023
10.8.3 OTHER DEVELOPMENTS
TABLE 166 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: OTHER DEVELOPMENTS, 2020–2023
11 COMPANY PROFILES
(Business overview, Products/Services/Solutions offered, Recent Developments, MNM view)*
11.1 KEY PLAYERS
11.1.1 JABIL INC.
TABLE 167 JABIL INC.: COMPANY OVERVIEW
FIGURE 28 JABIL INC.: COMPANY SNAPSHOT (2022)
11.1.2 FLEX LTD.
TABLE 168 FLEX LTD.: COMPANY OVERVIEW
FIGURE 29 FLEX LTD.: COMPANY SNAPSHOT (2022)
11.1.3 PLEXUS CORP.
TABLE 169 PLEXUS CORP.: COMPANY OVERVIEW
FIGURE 30 PLEXUS CORP.: COMPANY SNAPSHOT (2022)
11.1.4 SANMINA CORPORATION
TABLE 170 SANMINA CORPORATION: COMPANY OVERVIEW
FIGURE 31 SANMINA CORPORATION: COMPANY SNAPSHOT (2022)
11.1.5 TE CONNECTIVITY LTD.
TABLE 171 TE CONNECTIVITY LTD.: COMPANY OVERVIEW
FIGURE 32 TE CONNECTIVITY LTD.: COMPANY SNAPSHOT (2022)
11.1.6 CELESTICA INC.
TABLE 172 CELESTICA INC.: COMPANY OVERVIEW
FIGURE 33 CELESTICA INC.: COMPANY SNAPSHOT (2022)
11.1.7 INTEGER HOLDINGS CORPORATION
TABLE 173 INTEGER HOLDINGS CORPORATION: COMPANY OVERVIEW
FIGURE 34 INTEGER HOLDINGS CORPORATION: COMPANY SNAPSHOT (2022)
11.1.8 NIPRO CORPORATION
TABLE 174 NIPRO CORPORATION: COMPANY OVERVIEW
FIGURE 35 NIPRO CORPORATION: COMPANY SNAPSHOT (2022)
11.1.9 THERMO FISHER SCIENTIFIC
TABLE 175 THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW
FIGURE 36 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2022)
11.1.10 WEST PHARMACEUTICAL SERVICES, INC.
TABLE 176 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY OVERVIEW
FIGURE 37 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT (2022)
11.1.11 BENCHMARK ELECTRONICS INC.
TABLE 177 BENCHMARK ELECTRONICS INC.: COMPANY OVERVIEW
FIGURE 38 BENCHMARK ELECTRONICS INC.: COMPANY SNAPSHOT (2022)
11.1.12 KIMBALL ELECTRONICS INC.
TABLE 178 KIMBALL ELECTRONICS INC.: COMPANY OVERVIEW
FIGURE 39 KIMBALL ELECTRONICS INC.: COMPANY SNAPSHOT (2022)
11.1.13 KMC SYSTEMS
TABLE 179 KMC SYSTEMS: COMPANY OVERVIEW
11.1.14 SAVYON DIAGNOSTICS
TABLE 180 SAVYON DIAGNOSTICS: COMPANY OVERVIEW
11.1.15 NOVA BIOMEDICAL
TABLE 181 NOVA BIOMEDICAL: COMPANY OVERVIEW
11.2 OTHER PLAYERS
11.2.1 CENOGENICS CORPORATION
11.2.2 CONE BIOPRODUCTS
11.2.3 AVIOQ, INC.
11.2.4 PHILLIPS-MEDISIZE CORPORATION
11.2.5 INVETECH
11.2.6 MERIDIAN BIOSCIENCE, INC.
11.2.7 NOLATO AB
11.2.8 FUJIREBIO
11.2.9 SEKISUI
11.2.10 PRESTIGE DIAGNOSTICS
11.2.11 BIOKIT
*Details on Business overview, Products/Services/Solutions offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
